Northend, M., Wilson, W., Osborne, W., Fox, C. P., Davies, A. J., El‐Sharkawi, D., Phillips, E. H., Sim, H. W., Sadullah, S., Shah, N., Peng, Y. Y., Qureshi, I., Addada, J., Mora, R. F., Phillips, N., Kuhnl, A., Davies, E., Wrench, D., McKay, P., Karpha, I., Cowley, A., Karim, R., Challenor, S., Singh, V., Burton, C., Auer, R., Williams, C., Broom, A., Roddie, C., & Townsend, W. (n.d.). pOLATUZUMAB VEDOTIN WITH BENDAMUSTINE AND RITUXIMAB FOR RELAPSED/REFRACTORY HIGH‐GRADE B‐CELL LYMPHOMA: THE UK EXPERIENCE. Hematological oncology, 39, n/a. http://access.bl.uk/ark:/81055/vdc_100133622825.0x000035